{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-050569","form_type":"8-K","ticker":"CC","cik":"0001627223","company_name":"Chemours Co","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.310718+00:00","generated_at":"2026-06-03T04:29:13.241197+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Chemours Q1 earnings: net sales $1.35B (-12% YoY), net income $52M, adj EBITDA $193M","bullets":["Net sales $1.35B, down 12% YoY; volumes -6%, price -5%.","Net income attributable to Chemours $52M ($0.34 per diluted share) vs $145M ($0.96) in Q1 2023.","Adjusted EBITDA $193M vs $304M (-37%).","Cash flows used in operations -$290M; capex $102M; dividends $37M.","Segment declines: APM -23%, TT -7%, TSS -8%."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-050569","json":"https://secwatch.observer/filing/0000950170-24-050569.json","markdown":"https://secwatch.observer/filing/0000950170-24-050569.md","text":"https://secwatch.observer/filing/0000950170-24-050569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/0000950170-24-050569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/cc-20240430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T04:29:13.241197+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5d95345c42ccf8bffe966abf3339352c3a2b344f","claim":"Chemours Co reported first quarter 2024 results: revenue $1.4 billion, net income $52 million, or $0.34 per diluted share, EPS $0.34 per diluted share.","evidence_excerpt":"Solutions (“TSS”), and Advanced Performance Materials (“APM”), today announced its financial results for the first quarter 2024. Key First Quarter 2024 Results • Net Sales of $1.4 billion, down 12% year-over-year • Net Income attributable to Chemours of $52 million, or $0.34 per diluted share, compared with $145 million, or $0.96 per diluted share, in the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017024050569/0000950170-24-050569-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2024"},{"label":"Revenue","value":"$1.4 billion"},{"label":"Net income","value":"$52 million, or $0.34 per diluted share"},{"label":"EPS","value":"$0.34 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}